PTGX insider disclosures
Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source | Follow |
|---|---|---|---|---|---|---|---|
| PATEL DINESH V PH D President and CEO · Director · Protagonist Therapeutics, Inc | PTGX Protagonist Therapeutics, Inc | Gift or transferFiling detailsSEC transaction code G Common Stock · Direct ownership · Reported balance after transaction: 522668 · This transaction involves a bona fide gift of securities from the Reporting Person to a relative. | 2026-11-19 | 2026-11-20 | 300 shares/units | SEC 4 | Follow |
| MOLINA ARTURO MD Chief Medical Officer · Protagonist Therapeutics, Inc | PTGX Protagonist Therapeutics, Inc | SellFiling detailsSEC transaction code S Common Stock · Direct ownership · Reported balance after transaction: 81397 · SEC code covers open-market or private transactions · Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. | 2026-11-16 | 2026-11-17 | ≈ $338,798.70 2,718 shares/units | SEC 4 | Follow |
Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.